Summary
The process by which transmissible spongiform encephalopathy (TSE) agents, or prions, infect cells is unknown. There are also no effective treatments available for TSE diseases. Studies of cultured cells persistently infected with TSE agents have greatly contributed to understanding these and many other aspects of TSE disease. New cell lines have been developed to increase the repertoire of TSE strains that can be investigated in ex vivo models. Candidates for TSE therapeutics have been identified. Initial events involving the internalization and trafficking of TSE agents and the effect of membranes on the infection process have been examined. Recent progress in these areas is discussed below, which together illustrate the value of cell culture models in the study of prion diseases.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Clarke MC, Haig DA (1970) Multiplication of scrapie agent in cell culture. Res Vet Sci 11:500–501
Clarke MC, Haig DA (1970) Evidence for the multiplication of scrapie agent in cell culture. Nature 225:100–101
Haig DA, Clarke MC (1971) Multiplication of the scrapie agent. Nature 234:106–107
Birkett CR, Hennion RM, Bembridge DA et al (2001) Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 20:3351–3358
Clarke MC, Millson GC (1976) Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature 261:144–145
Vorberg I, Raines A, Story B et al (2004) Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J Infect Dis 189:431–439
Follet J, Lemaire-Vieille C, Blanquet-Grossard F et al (2002) PrP expression and replication by Schwann cells: implications in prion spreading. J Virol 76:2434–2439
Archer F, Bachelin C, Andreoletti O et al (2004) Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol 78:482–490
Vilette D, Andreoletti O, Archer F et al (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci U S A 98:4055–4059
Bosque PJ, Prusiner SB (2000) Cultured cell sublines highly susceptible to prion infection. J Virol 74:4377–4386
Enari M, Flechsig E, Weissmann C (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci USA 98:9295–9299
Nishida N, Harris DA, Vilette D et al (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 74:320–325
Kimberlin RH, Walker CA (1978) Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 39:487–496
Schatzl HM, Laszlo L, Holtzman DM et al (1997) A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 71:8821–8831
Rubenstein R, Carp RI, Callahan SM (1984) In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol 65:2191–2198
Rubenstein R, Scalici CL, Papini MC et al (1990) Further characterization of scrapie replication in PC12 cells. J Gen Virol 71:825–831
Cronier S, Laude H, Peyrin JM (2004) Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci U S A 101:12271–12276
Sabuncu E, Petit S, Le Dur A et al (2003) PrP polymorphisms tightly control sheep prion replication in cultured cells. J Virol 77:2696–2700
Rubenstein R, Deng H, Race RE et al (1992) Demonstration of scrapie strain diversity in infected PC12 cells. J Gen Virol 73:3027–3031
Vorberg I, Raines A, Priola SA (2004) Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J Biol Chem 279:29218–29225
Kocisko DA, Baron GS, Rubenstein R et al (2003) New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 77:10288–10294
Cashman NR, Caughey B (2004) Prion diseases-close to effective therapy? Nature Reviews Drug Discovery
Kocisko DA, Morrey JD, Race RE et al (2004) Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. J Gen Virol 85:2479–2483
Maxson L, Wong C, Herrmann LM et al (2003) A solid-phase assay for identification of modulators of prion protein interactions. Anal Biochem 323:54–64
Bueler H, Aguzzi A, Sailer A et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347
Mallucci GR, Ratte S, Asante EA et al (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21:202–210
Tremblay P, Meiner Z, Galou M et al (1998) Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci U S A 95:12580–12585
Mallucci G, Dickinson A, Linehan J et al (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871–874
Daude N, Marella M, Chabry J (2003) Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J Cell Sci 116:2775–2779
Leucht C, Simoneau S, Rey C et al (2003) The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep 4:290–295
Kocisko DA, Come JH, Priola SA et al (1994) Cell-free formation of protease-resistant prion protein. Nature 370:471–474
Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810–813
Lucassen R, Nishina K, Supattapone S (2003) In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 42:4127–4135
Morillas M, Swietnicki W, Gambetti P et al (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 274:36859–36865
Sanghera N, Pinheiro TJ (2002) Binding of prion protein to lipid membranes and implications for prion conversion. J Mol Biol 315:1241–1256
Baron GS, Wehrly K, Dorward DW et al (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 21:1031–1040
Baron GS, Caughey B (2003) Effect of glycosylphosphatidylinositol anchor-dependent and-independent prion protein association with model raft membranes on conversion to the protease-resistant Isoform. J Biol Chem 278:14883–14892
Blusztajn JK, Venturini A, Jackson DA et al (1992) Acetylcholine synthesis and release is enhanced by dibutyryl cyclic AMP in a neuronal cell line derived from mouse septum. J Neurosci 12:793–799
Barbosa J, Jr., Massensini AR, Santos MS et al (1999) Expression of the vesicular acetylcholine transporter, proteins involved in exocytosis, and functional calcium signaling in varicosities and soma of a murine septal cell line. J Neurochem 73:1881–1893
Kushmerick C, Romano-Silva MA, Gomez MV et al (2001) Changes in Ca(2+) channel expression upon differentiation of SN56 cholinergic cells. Brain Res 916:199–210
Mack M, Kleinschmidt A, Bruhl H et al (2000) Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6:769–775
Batista FD, Iber D, Neuberger MS (2001) B cells acquire antigen from target cells after synapse formation. Nature 411:489–494
Liu T, Li R, Pan T et al (2002) Intercellular transfer of the cellular prion protein. J Biol Chem 277:47671–47678
Ilangumaran S, Robinson PJ, Hoessli DC (1996) Transfer of exogenous glycosylphos-phatidylinositol (GPI)-linked molecules to plasma membranes. Trends Cell Biol 6:163–167
Medof ME, Nagarajan S, Tykocinski ML (1996) Cell-surface engineering with GPI-anchored proteins. FASEB J 10:574–586
Safar J, Ceroni M, Piccardo P et al (1990) Subcellular distribution and physicochemical properties of scrapie-associated precursor protein and relationship with scrapie agent. Neurology 40:503–508
Bolton DC, Rudelli RD, Currie JR et al (1991) Copurification of Sp33–37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease. J Gen Virol 72 ( Pt 12):2905–2913
Fevrier B, Vilette D, Archer F et al (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 101:9683–9688
McKinley MP, Meyer RK, Kenaga L et al (1991) Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65:1340–1351
Gabizon R, McKinley MP, Prusiner SB (1987) Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 84:4017–4021
Gabizon R, McKinley MP, Groth DF et al (1988) Properties of scrapie prion protein liposomes. J Biol Chem 263:4950–4955
Caughey B, Raymond GJ, Callahan MA et al (2001) Interactions and conversions of prion protein isoforms. Adv Prot Chem 57:139–169
Stoorvogel W, Kleijmeer MJ, Geuze HJ et al (2002) The biogenesis and functions of exosomes. Traffic 3:321–330
Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–579
Mayer RJ, Landon M, Laszlo L et al (1992) Protein processing in lysosomes: the new therapeutic target in neurodegenerative disease. Lancet 340:156–159
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this paper
Cite this paper
Baron, G.S. (2005). Prion protein interactions and TSE infections in cell culture models. In: Kitamoto, T. (eds) Prions. Springer, Tokyo. https://doi.org/10.1007/4-431-29402-3_11
Download citation
DOI: https://doi.org/10.1007/4-431-29402-3_11
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-25539-0
Online ISBN: 978-4-431-29402-3
eBook Packages: MedicineMedicine (R0)